Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma

Glucose-6-phosphate isomerase (GPI), also known as phosphoglucose isomerase, was initially identified as the second glycolytic enzyme that catalyzes the interconversion of glucose-6-phosphate to fructose-6-phosphate. Later studies demonstrated that GPI was the same as the autocrine motility factor (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucarelli, Giuseppe, Rutigliano, Monica, Sanguedolce, Francesca, Galleggiante, Vanessa, Giglio, Andrea, Cagiano, Simona, Bufo, Pantaleo, Maiorano, Eugenio, Ribatti, Domenico, Ranieri, Elena, Gigante, Margherita, Gesualdo, Loreto, Ferro, Matteo, de Cobelli, Ottavio, Buonerba, Carlo, Di Lorenzo, Giuseppe, De Placido, Sabino, Palazzo, Silvano, Bettocchi, Carlo, Ditonno, Pasquale, Battaglia, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652838/
https://www.ncbi.nlm.nih.gov/pubmed/26579829
http://dx.doi.org/10.1097/MD.0000000000002117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652838/
https://www.ncbi.nlm.nih.gov/pubmed/26579829
http://dx.doi.org/10.1097/MD.0000000000002117

Ejemplares similares